But in another study conducted on 142 Chinese patients with colorectal and nasopharyngeal cancers receiving 5-FU-treated regimens, the prevalence of the 2194 G > A polymorphism was reported 1.4% and there was not any relationship with the DPD enzyme activity [26]. The gene discussed is DPYD; the disease is nasopharyngeal carcinoma.